Lily Tran
Neurology with Special Qualifications in Child Neurology · Wilmington, DENPI 1487865523
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,402 of the $5,251 with a category attached, or 64.8%. It is spread thinly across 21 manufacturers, the largest accounting for just 20.1%. Reporting peaked in 2019 at $2,561 and has fallen 89.4% since, to $272 in 2025.
Across 93 payments — averaging $56.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$1K
- Monteris Medical Corporation$1K
- UCB, Inc.$812
- Neuropace, Inc.$520
- Livanova USA, Inc.$398
- Greenwich Biosciences, Inc.$377
- plus $1K from 15 others
Across 21 payments — averaging $9948.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Immedica Pharma US, Inc.$209K
What the payments were for
- Speaking & faculty fees$68013%
- Travel & lodging$99219%
- Food & beverage$3,40265%
- Education$1773%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 18 | $1,053 |
| Monteris Medical Corporation | 8 | $1,038 |
| UCB, Inc. | 13 | $812 |
| Neuropace, Inc. | 3 | $520 |
| Livanova USA, Inc. | 10 | $398 |
| Greenwich Biosciences, Inc. | 8 | $377 |
| Medtronic | 3 | $168 |
| Mallinckrodt Enterprises LLC | 5 | $146 |
| Jazz Pharmaceuticals Inc. | 2 | $125 |
| Zogenix Inc. | 3 | $121 |
| SK Life Science, Inc. | 4 | $104 |
| Immedica Pharma US, Inc. | 1 | $99 |
| Aquestive Therapeutics, Inc. | 5 | $78 |
| AstraZeneca | 1 | $70 |
| Novartis | 2 | $44 |
| Masimo Corporation | 1 | $28 |
| Upsher-smith Laboratories LLC | 1 | $27 |
| Mallinckrodt Hospital Products Inc. | 1 | $14 |
| Neurelis, Inc. | 1 | $14 |
| Travere Therapeutics, Inc. | 2 | $9 |
| Sumitomo Pharma America, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Neuroblate$797
- APTIOM$680
- RNS System$441
- Briviact$331
- Fintepla$213
- Epidiolex$133
- VNS Therapy$125
How this compares
Too few neurology with special qualifications in child neurology providers in Delawareto place this figure against a meaningful peer group, so we don't.
Other neurology with special qualifications in child neurology in Wilmington
- Harry ChuganiWilmington$69K
- Stephen FalchekWilmington$6K
- Mena ScavinaWilmington$5K
- Badal JainWilmington$2K
- Sumair HusainWilmington$443
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.